首页> 外文期刊>American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons >Long‐term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation
【24h】

Long‐term outcomes of transmesenteric portal vein recanalization for the treatment of chronic portal vein thrombosis after pediatric liver transplantation

机译:转化率门静脉重量的长期结果,用于治疗儿科肝移植后慢性门静脉血栓形成

获取原文
获取原文并翻译 | 示例
           

摘要

Portal vein thrombosis (PVT) may occur at any time following liver transplantation. We describe our experience with portal vein recanalization in cases of thrombosis after liver transplantation. Twenty‐eight children (5%) out of 566 liver transplant recipients underwent portal vein recanalization using a transmesenteric approach. All children received left hepatic segments, developed PVT, and had symptoms or signs of portal hypertension. Portal vein recanalization was performed via the transmesenteric route in all cases. Twenty‐two (78.6%) patients underwent successful recanalization and stent placement. They received oral anticoagulants after the procedure, and clinical symptoms subsided. Symptoms recurred due to portal vein restenosis/thrombosis in seven patients. On an intention‐to‐treat basis, the success rate of the proposed treatment was 60.7%. Only 17 out of 28 children with posttransplant chronic PVT retained stent patency (primary?+?assisted) at the end of the study period. In cases of portal vein obstruction, the transmesenteric approach via minilaparotomy is technically feasible with good clinical and hemodynamic results. It is an alternative procedure to reestablish the portal flow to the liver graft that can be performed in selected cases and a therapeutic addition to other treatment strategies currently used to treat chronic PVT.
机译:门静脉血栓形成(PVT)可能在肝移植后的任何时间发生。我们在肝移植后血栓形成的病例中描述了我们对门静脉重新化的经验。 566个肝移植接受者中的二十八名儿童(5%)使用传输方法接受门静脉重量的门静脉重新组分。所有儿童接受左肝区段,发育PVT,具有门静脉高血压的症状或迹象。在所有情况下,通过传输路由进行门户静脉再生。二十二(78.6%)患者经历了成功的再生和支架展示。他们在程序后接受了口腔抗凝血剂,临床症状消退。由于七名患者的门静脉再狭窄/血栓形成症状重复。以意向治疗的基础,拟议治疗的成功率为60.7%。 28名儿童中只有17名患有后翻版慢性PVT在研究期结束时保留支架通畅(主要?+辅助)。在门静脉阻塞的情况下,通过MiniLaparotomy的传输方法在技术上是可行的,临床和血液动力学结果。它是重新建立到肝脏移植物的门户流动的替代方法,其可以在选定病例和目前用于治疗慢性PVT的其他治疗策略的治疗性添加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号